期刊文献+

不同剂量右美托咪定对腹腔镜子宫肌瘤剔除术患者呼气末异氟烷浓度的影响 被引量:15

下载PDF
导出
摘要 目的观察不同剂量右美托咪定(dexmedetomidine,DEX)对腹腔镜子宫肌瘤剔除术患者呼气末异氟烷浓度(end-tidal isoflurane concentration,ETiso)的影响,并探讨其对ETiso的影响有无剂量依赖性。方法选择择期全麻下行腹腔镜子宫肌瘤剔除术患者80例,分成4组,每组20例:对照组(C组),生理盐水20 mL静脉泵注10 min;低剂量DEX组(D1组),DEX 0.3μg/kg用生理盐水稀释成20 mL,静脉泵注10 min;中剂量DEX组(D2组),DEX 0.6μg/kg,给药方法同D1组;高剂量DEX组(D3组),DEX 0.9μg/kg,给药方法同D1组。记录患者入室静卧10 min(T0)、麻醉诱导后即刻(T1)、切皮时(T3)、气腹即刻(T4)、气腹后15 min(T5)、气腹后30 min(T6)和术毕即刻(T7)时的平均动脉压(MAP)和心率(HR),记录给予DEX前即刻(T2)、T3、T4、T5、T6、T7时的ETiso。结果与C组比较,其他3组于T3、T4、T5、T6、T7时HR均降低(P<0.05),D1组于T3、T4时MAP降低,D2组于T3、T4、T6、T7时MAP降低,D3组于T3、T4、T5、T6、T7时MAP降低,差异均有统计学意义(P<0.05);与D1组比较,D2组和D3组于T3、T4时MAP降低(P<0.05),D2组和D3组于T3、T4、T5、T6、T7时HR均降低(P<0.05);与D2组比较,D3组HR于T4、T5、T6、T7时降低(P<0.05)。与C组比较,其他3组于T3、T4、T5、T6、T7时ETiso明显降低(P<0.05);与D1组比较,D2组和D3组于T3、T4、T5、T6、T7时ETiso明显降低(P<0.05);与D2组比较,D3组于T3、T4、T5、T6、T7时ETiso明显降低(P<0.05)。结论 DEX可剂量依赖性地降低腹腔镜子宫肌瘤剔除术患者的ETiso。
出处 《广东医学》 CAS CSCD 北大核心 2012年第1期117-119,共3页 Guangdong Medical Journal
  • 相关文献

参考文献8

  • 1吴新民,许幸,王俊科,王鲲鹏,薛张纲,缪长虹,邓小明,艾登斌,于浩.静脉注射右美托咪啶辅助全身麻醉的有效性和安全性[J].中华麻醉学杂志,2007,27(9):773-776. 被引量:242
  • 2KHAN Z P, FERGUSON C N, JONES R M. Alpha -2 and imid- azoline receptor agonists: their pharmacology and therapeutic role [J]. Anesthesia, 1999, 54(2): 146-165.
  • 3邹鑫,王世端,冯伟.右美托咪定2种剂量对靶控输注丙泊酚效应室浓度的影响[J].中国新药与临床杂志,2010,29(10):778-782. 被引量:18
  • 4EBERT T J, HALL J E, BARNEY J A, et al. The effects of in- crease plasma concentration of dexmedetomidine in humans [ J ]. Anesthesiology, 2000, 93 ( 3 ) : 382 - 394.
  • 5DUTTA S, KAROL M D, COHEN T, et al. Effect of dexmedeto- midine on propofol requirements in healt hysubjects [ J ]. Pharm Sci, 2001,90(2) : 172 -181.
  • 6KHAN Z P, MUNDAY I T, JONES R M, et al. Effects of dexme- detomidine on isoflurane requirements in healthy volunteers. 1: pharmacodynamic and pharmacokinetic interactions [ J ]. Br J Anaesth, 1999, 83 (3) : 372 - 380.
  • 7FRAGEN R J, FITZGERALD P C. Effects of dexmedetomidine on the minimum alveolar concentration (MAC) of isoflurane in adults age 55 to 70 years[J]. Clin Anesth, 1999, 11 (6) : 466 -470.
  • 8高建瓴,詹英,杨建平,金晓红,李健.右美托咪定辅助全身麻醉患者的镇静及全身麻醉药物的节俭作用[J].上海医学,2010,33(6):525-527. 被引量:133

二级参考文献13

  • 1佘守章,李慧玲,许学兵,莫世湟.右旋美托咪啶的镇静效应及其对全麻镇静深度的影响[J].临床麻醉学杂志,2006,22(1):10-12. 被引量:105
  • 2Khan Z P,Munday I T,Jones R M,et al.Effects of dexmedetomidine on isoflurane requirements in healthy volunteers.1:Pharmacodynamic and pharmacokinetic interactions.Br J Anaesth,1999,83:372-380.
  • 3Fragen R J,Fitzgerald P C.Effect of dexmedetomidine on the minimum alveolar concentration (MAC) of sevoflurane in adults age 55 to 70 years.J Clin Anesth,1999,11:466-470.
  • 4Venn R M,Hell J,Grounds R M.Respiratory effects of dexmedetomidine in the surgical patient requiring intensive care.Crit Care,2000,4:302-308.
  • 5Angst M S,Ramaswamy B,Davies M F,et al.Comparative analgesic and mental effects of increasing plasma concentrations of dexmedetomidine and alfentanil in humans.Anesthesiology,2004,101:744-752.
  • 6Herr D L,Sum-Ping S T,England M.ICU sedation after coronary artery bypass graft surgery:dexmedetomidine-based versus propofol-based sedation regimens.J Cardiothorac Vasc Anesth,2003,17:576-584.
  • 7Elbaradie S,El Mahalawy F H,Solyman A H.Dexmedetomidine vs.propofol for short-term sedation of postoperative mechanically ventilated patients.J Egypt Natl Canc Inst,2004,16:153-158.
  • 8Durta S,Karol M D,Cohen T,et al.Effect of dexmedetomidine on propofol requirements in healthy subjects.J Pharm Sci,2001,90:172-181.
  • 9Wijeysundera DN, Naik JS, Beatfie WS. Alpha-2 adrenergic agonists to prevent perioperative cardiovascular complications : a meta-analysis. Am J Med, 2003,114:742-752.
  • 10Venn M, Newman J, Grounds M. A phase Ⅱ study to evaluate the efficacy of dexmedetomidine for sedation in the medical intensive care unit. Intensive Care Med, 2003, 29 : 201-207.

共引文献380

同被引文献108

  • 1乐杰.妇产科学[M].7版.北京:人民卫生出版社,2009:92-99.
  • 2Dere K, Sucullu I, Budak ET, et al. A comparison of dexme- detomidine versus midazolam for sedation pain and hemody- namic control during colonoscopy under conscious sedation [ J]. Eur J Anaesthesio1,2010,27:648-652.
  • 3Kang WS, Kim SY, Son JC, et al. The effect of dexmedetomi- dine on the adjuvant propofol requirement and intraoperative hemodynarnics during remifeatanil-based anesthesia[J]. Kore- an J Anesthesio1,2012,62 (2) : 113-118.
  • 4He L, Xu JM, Dai RP. Dexmedetomidine reduces the incidence of fentanyl-induced cough: a double-blind, randomized, and placebo-controlled study[J]. Ups J Med Sci, 2012,117 ( 1 ) : 18-21.
  • 5Afonso J, Reis F. Dexmedetomidine: current role in anesthesia and intensive care [ J ]. Rev Bras Anestesiol,2012,62 ( 1 ) : 118- 133.
  • 6Na HS, Song IA, Park HS, et al. Dexmedetomidine is effective for monitored anesthesia care in outpatients undergoing cataract surgery [ J ]. Korean J Anesthesio1,2011,61 ( 6 ) :453-459.
  • 7Kamibayashi T, Maze M. Clinical uses of alpha 2 adrenergic agonists [J]. Anesthesiology ,2000,93 ( 5 ) : 1345-1349.
  • 8Hoy S M, Keating G M. I)exmedetomidine: a review of its use for sedation in mechanically ventilated patients in an in- tensive care setting and for procedural sedation [J ]. Drugs, 2011, 71(11): 1481.
  • 9Riker R R, Shehabi Y, Bokesch P M, et al. Dexmedetomi- dine vs midazolam for sedation of critically ill patients: a ran- domized trial[J]. JAMA, 2009, 301(5): 489.
  • 10Chrysostomou C, Schmitt C G. Dexmedetomidine: sedation, analgesia and beyond[Jl. Expert Opin Drug Metab Toxicol, 2008, 4(5): 619.

引证文献15

二级引证文献80

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部